# Merck KGaA Agrees to Acquire Bio-Techne for $11.3 Billion in Landmark Life-Science Tools Deal

> ma · REPORTED · 2026-06-24

Merck KGaA announced a definitive agreement to acquire Bio-Techne for $11.3 billion, its largest acquisition since Sigma-Aldrich in 2014, gaining a broad portfolio of proteins, antibodies, reagents, multi-omics tools, spatial biology, and cell and gene therapy workflow solutions. The deal is one of three transactions each exceeding $10 billion announced within a single week in late June 2026 alongside AbbVie's $10.9 billion purchase of Apogee Therapeutics and GSK's $10.6 billion acquisition of Nuvalent.

About Merck KGaA: Merck KGaA is a German science and technology company whose Life Science division supplies research reagents, bioprocessing tools, and analytical technologies to pharmaceutical and biotech customers globally.

- Company: Merck KGaA
- Sector: life-science tools
- Primary source: https://www.medicaldevice-network.com/news/merck-kgaa-to-buy-bio-techne-for-11-3bn-in-life-science-footprint-expansion/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.